Program Code: SCF-DBI-NICU-NEURO-0001

Operational Window: Birth → NICU Discharge → Neurodevelopmental Follow-Up

Primary Objective: Preserve developmental neural intelligence, prevent secondary neurologic injury, support adaptive neurodevelopment, and optimize long-term cognitive and functional outcomes.

SECTION 7.1

CLINICAL POSITIONING

Traditional Neurocritical NICU Model

Focuses on:

• Neurologic examination
• Cranial ultrasound
• EEG
• Therapeutic hypothermia
• Seizure management

SCF-DBI Neurodevelopmental Model

The neonatal brain is viewed as a dynamic biological intelligence network coordinating:

Neuroimmune signaling

Neurovascular adaptation

Metabolic programming

Endocrine regulation

Developmental plasticity

Long-term cognitive architecture

Core Principle

Brain injury is often amplified by secondary disturbances occurring after the initial insult.

The goal is preservation of developmental intelligence, not merely survival.

SECTION 7.2

RHENOVA NEURODEVELOPMENT PRESERVATION BUNDLE (NPB)

Full Deployment Protocol

Activation Criteria

Automatically activated for:

• Gestational age <32 weeks
• HIE
• IVH risk
• Seizures
• Severe respiratory failure
• Shock
• ECMO
• Surgical critical illness

NPB COMPONENT 1

Cerebral Oxygen Stewardship

Prevent:

Cerebral hypoxia

Hyperoxia

Perfusion instability

NPB COMPONENT 2

Developmental Environment Control

Maintain:

Noise reduction

Circadian preservation

Sleep protection

Developmentally appropriate handling

NPB COMPONENT 3

Neuroinflammation Prevention

Monitor:

Sepsis risk

Cytokine activation

Neuroimmune instability

NPB COMPONENT 4

Neurovascular Stabilization

Maintain:

Cerebral perfusion

Blood pressure stability

Endothelial integrity

SECTION 7.3

CEREBRAL OXYGENATION SURVEILLANCE SYSTEM (COSS)

Purpose

Continuously assess cerebral oxygen delivery and utilization.

Surveillance Domains

Domain A

Cerebral Oxygen Supply

Monitor:

NIRS

Oxygenation

Hemoglobin

Perfusion

Domain B

Cerebral Utilization

Monitor:

Lactate

Acid-base balance

Neurologic examination

Domain C

Neurovascular Stability

Monitor:

Blood pressure variability

Perfusion

Endothelial status

Output

Cerebral Adaptation Index (CAI)

SECTION 7.4

HYPOXIC-ISCHEMIC ENCEPHALOPATHY (HIE) SOP

Clinical Positioning

HIE is viewed as:

Developmental Intelligence Injury Syndrome

resulting from:

• Oxygen deprivation
• Ischemia
• Neuroimmune activation
• Endothelial injury
• Metabolic disruption

HIE Severity Classification

Stage I

Mild

Stage II

Moderate

Stage III

Severe

HIE Immediate Assessment

Evaluate:

Apgar history

Resuscitation history

Cord gases

Neurologic examination

EEG

NIRS

SECTION 7.5

THERAPEUTIC HYPOTHERMIA WORKFLOW

Eligibility

Per institutional and guideline criteria.

SCF Objectives

Traditional Objective:

Reduce neurologic injury.

SCF Objective:

Preserve developmental intelligence architecture.

Monitoring During Hypothermia

EEG

Cerebral oxygenation

ANMS

Neuroimmune status

Perfusion

SECTION 7.6

INTRAVENTRICULAR HEMORRHAGE (IVH) PREVENTION PROGRAM

Strategic Position

IVH is frequently associated with unstable cerebral adaptation.

Risk Factors

Prematurity

Hemodynamic instability

Rapid volume shifts

Respiratory instability

Coagulopathy

Prevention Bundle

Perfusion Stability

Avoid rapid BP fluctuations.

Gentle Ventilation

Avoid:

Hypercapnia

Hypocapnia

Developmental Positioning

Maintain neutral head position when indicated.

Glycocalyx Protection Bundle

Protect fragile cerebral vasculature.

SECTION 7.7

IVH SURVEILLANCE PROTOCOL

Imaging

Cranial ultrasound

At risk-based intervals.

Clinical Monitoring

Neurologic status

Fontanel examination

Hemodynamics

SCF Monitoring

Neurovascular Stability Score

ANMS

Endothelial Integrity Index

IVH Classification

Grade I

Grade II

Grade III

Grade IV

SECTION 7.8

NEONATAL SEIZURE MANAGEMENT WORKFLOW

Immediate Assessment

Evaluate:

Clinical events

EEG confirmation

Metabolic abnormalities

Infection risk

Structural injury

Seizure Stabilization Bundle

Airway

Breathing

Circulation

Glucose

Temperature

Neurologic Surveillance

SCF Neurodevelopmental Goal

Prevent secondary neural injury during seizure management.

SECTION 7.9

RHENOVA BRAIN PROTECTION PROTOCOL

Strategic Objective

Prevent propagation of neurologic injury.

Core Threats

Neuroinflammation

Endothelial injury

Oxidative stress

Mitochondrial dysfunction

Sleep disruption

Perfusion instability

Protection Components

Neuroimmune Stabilization

Glycocalyx Preservation

Metabolic Optimization

Sleep Architecture Protection

Developmental Environment Control

SECTION 7.10

NEURODEVELOPMENTAL ANMS FRAMEWORK

Neuroimmune Domain

Monitor:

Cytokine burden

Infection risk

STRI

Neurovascular Domain

Monitor:

Cerebral perfusion

NIRS

Endothelial status

Neurometabolic Domain

Monitor:

Lactate

Glucose stability

Neuroendocrine Domain

Monitor:

Stress burden

Sedation exposure

Neurodevelopmental ANMS Classification

Green

ANMS >80

Stable adaptation

Yellow

ANMS 60–79

Compensated stress

Orange

ANMS 40–59

Threatened neurodevelopment

Red

ANMS <40

High neurologic deterioration risk

SECTION 7.11

NEUROLOGIC ESCALATION PATHWAY

Level 0

Routine monitoring

Level 1

Enhanced surveillance

Triggers:

ANMS decline

NIRS abnormalities

Level 2

Neurology consultation

Triggers:

EEG abnormalities

Progressive neurologic findings

Level 3

Neurocritical escalation

Triggers:

Seizures

Severe HIE

Progressive IVH

SECTION 7.12

NEURODEVELOPMENTAL RECOVERY PROGRAM

Recovery Domains

Neural adaptation

Cognitive architecture

Neuroimmune recovery

Neurovascular recovery

Developmental progression

Monitoring

EEG

NIRS

Growth

Neurologic examination

ANMS

SECTION 7.13

DISCHARGE NEURODEVELOPMENTAL READINESS CRITERIA

Clinical

No uncontrolled seizures

Stable neurologic examination

Stable feeding

SCF

Stable ANMS

Stable CAI

Stable STRI

Developmental

Appropriate progression trajectory

Follow-up pathway established

SECTION 7.14

NEURODEVELOPMENTAL RECOVERY ENDPOINTS

Short-Term

Neurologic stability

Feeding success

Stable growth

Intermediate

Preserved developmental milestones

Reduced neurologic morbidity

Long-Term

Cognitive resilience

Functional independence

Developmental optimization

PAGE 7 COMPLETION

Next Page (Page 8):

Growth Failure & Nutrition Intelligence SOP

Stem Cell Preservation Strategy (Full Deployment)

Human Milk Intelligence Program

TPN Management Workflow

Metabolic Intelligence Surveillance System

Bone Marrow Niche Preservation Program

Growth Recovery & Developmental Optimization Framework

MASTER REGISTRY INDEX

SCF-DBI-NICU-NEURO-0001 — Neurocritical Care SOP

SCF-RHENOVA-NPB-0001 — Neurodevelopment Preservation Bundle

SCF-COSS-0001 — Cerebral Oxygenation Surveillance System

SCF-CAI-0001 — Cerebral Adaptation Index

SCF-DBI-NICU-HIE-0001 — HIE Management SOP

SCF-DBI-NICU-IVH-0001 — IVH Prevention Program

SCF-DBI-NICU-SEIZURE-0001 — Neonatal Seizure Workflow

SCF-RHENOVA-BPP-0001 — Brain Protection Protocol

SCF-ANMS-NEURO-0001 — Neurodevelopmental ANMS Framework

SCF-RHENOVA-NICU-NEURO-0001 — Project RHENOVA Neurodevelopment Intelligence Platform